Cannabis Law Report

JULY 13, 2022

Import, Advertising and Supply Compliance Priorities 2022-23. The table below sets out the TGA’s priority areas for compliance activities relating to the import, advertising and supply requirements of the Therapeutic Goods Act 1989 from 1 July 2022 to 30 June 2023. Import, Advertising and Supply Compliance Priorities 2022-23.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

NORML

FEBRUARY 22, 2019

Senate Bill 1003 / House Bill 2273 to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations. Legislation is pending, Senate Bill 8, as well as Senate Bill 598, to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations.

Legislation 192

Legislation Hemp Compliance Compliance 192

Cannabis Law Report

JULY 29, 2021

It is alleged that the individual referred to a prohibited representation in the website advertising of the CBD oil as a treatment for “cancerous tumours”. The TGA has informed the individual that the alleged unlawful website and social media advertising must be removed immediately. Source: [link].

Medicine 105

Medicine Oil Compliance Compliance 105

MMJ Recs

JULY 9, 2024

Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Veriheal

JULY 16, 2020

The commission tasked with developing recommendations to improve mental health treatment for veterans concluded: Congress and the executive branch need to promote research into the therapeutic potential of cannabis and psychedelics such as psilocybin mushrooms and MDMA. Veterans across the U.S.

Research and Development 97

Research and Development Clinical Trials Treatment Compliance 97

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance.

Digestion 124

Digestion Treatment Conditions Research and Development 124

Cannabis Law Report

FEBRUARY 27, 2020

Helene Moore (EAMC board member and Director General of Aurora France), has said the current challenges faced by the medicinal cannabis industry include standard compliance, regulatory fragmentation and lack of sufficient public funded research on medicinal cannabis.

Law 102

Law Medicine Compliance Compliance 102

Cannabis Law Report

AUGUST 30, 2021

provide free electronic payments within-network, powerful integrated banking capabilities, and automated compliance. Due to the nature of our business, we were able to walk away with expertise in financial service compliance. Underlying drivers to some of these problems are the financial compliance obligations to banks.

Banking 105

Banking Compliance Compliance Supply Chain 105

MMJ Recs

MAY 25, 2024

However, not many patients know the reasons behind how medical marijuana interacts with the body, so we prepared this comprehensive guide to use as a starting point for those considering cannabis treatment. However, further studies are needed to fully understand the mechanisms and potential of ECS modulation in mental health treatment.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

United Patients Group

JULY 7, 2023

3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments. Nausea and vomiting are common side effects of these treatments and can significantly impact a person’s quality of life.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

MJ Business Attorneys

JUNE 29, 2018

The FDA’s approval of the drug is just one step toward getting Epidiolex on the market and available to doctors to prescribe as a treatment option. Attorney Charles Feldmann has worked extensively with a variety of state agencies focused on enforcement, licensing, federal risk mitigation, and compliance.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

MMJ Recs

OCTOBER 26, 2023

It’s essential to be aware of the specific laws in your state to remain in compliance. These guidelines define who is eligible to use MMJ, what conditions qualify for treatment, and how patients can obtain medical cannabis cards. Compliance with state laws and regulations is essential to avoid legal issues.

Law 98

Law Marijuana Programs Conditions 98

Cannabis Law Report

JULY 2, 2021

The Medical Cannabis Clinics (TMCC) was awarded one of four licences to trade as a cannabis clinic by CQC in 2019, and provides treatment to patients across a number of medical areas including pain and psychiatry. Care and treatment was said to be delivered according to evidence- based guidelines and feedback from patients was positive.

Treatment 81

Treatment Patients Compliance Compliance 81

Cannabis Law Report

APRIL 17, 2023

. – Today, Congressman Earl Blumenauer, founder and co-chair of the Congressional Cannabis Caucus, introduced the Small Business Tax Equity Act which creates an exception to Internal Revenue Code Section 280E to allow marijuana businesses operating in compliance with state law to take deductions associated with the sale of marijuana like any […] (..)

Business 52

Business Treatment Compliance Compliance 52

NORML

JUNE 7, 2019

Legislation is pending, Senate Bill 315, to amend the state’s existing industrial hemp law to be in compliance with the new federal hemp regulations. Legislation is pending, Senate Bill 57, to establish an industrial hemp pilot program to be in compliance with the new federal hemp regulations. North Carolina. Update : S.

Legislation 136

Legislation Hemp Agriculture Compliance 136

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

JULY 25, 2024

Medical marijuana (MMJ) has emerged as a critical treatment option for various health conditions, prompting a shift toward online application processes. This understanding ensures efficient service delivery, compliance with legal requirements, and optimal patient care. This step ensures personalized care and treatment planning.

Compliance 52

Compliance Compliance Treatment Access 52

Veriheal

AUGUST 2, 2021

The researchers stated that the goal of the study was to “test the preclinical efficacy of a chronic CBD treatment” in the reduction of withdrawal symptoms as a result of nicotine dependence. We do not advise self-treatment with psilocybin, especially where illegal and illegal market purchases would be necessary. .

CBD 98

CBD Treatment Strains Sleep 98

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

United Patients Group

OCTOBER 25, 2023

From understanding the legality of medical marijuana to its efficacy in treating various medical conditions, our guide will equip you with essential knowledge and insights on this increasingly popular treatment option. Is Medical Marijuana Legal? What Conditions Can Medical Marijuana Treat? How Does Medical Marijuana Work?

Marijuana 105

Marijuana Patients Research and Development Edibles 105

Canna Law Blog

NOVEMBER 26, 2019

WSDA will apply the measurement of uncertainty (+/- 0.06%) outlined in the USDA’s interim hemp rules to the reported THC concentration to determine if hemp material is in compliance with the 2018 Farm Bill. Certifying that the WSDA has resources to undertake the Plan. THC Testing.

Hemp 105

Hemp Food Compliance Compliance 105

Cannabis Law Report

AUGUST 3, 2022

At the same time, the policy statement acknowledged that effective patient care requires the “free and unfettered exchange of information on treatment alternatives.”. A designated provider of the medical marijuana is responsible for bringing the medical marijuana to the patient and removing it after consumption. 2 [link]. 3 [link].

Research and Development 98

Research and Development Policy Patients Compliance 98

Cannabis Law Report

JULY 15, 2021

Nevertheless, descheduling would have a profound effect on the marijuana businesses operating in states which have already legalized use—either medically and/or recreationally—by normalizing income tax treatment, opening access to capital, and permitting interstate commerce in cannabis.

Compliance 81

Compliance Compliance THC Retail 81

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Additionally, stigma and misinformation surrounding medical marijuana persist, impacting public perception and patient access.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

JANUARY 18, 2024

They position cannabis as a legitimate and valuable treatment option within the broader medical community. Furthermore, the Cannabis Compliance & Risk Management Certificate prioritizes legal compliance and best practices amidst the industry’s rapid growth.

Education 116

Education Therapy Patients Research and Development 116

Medicinal Marijuana Association

FEBRUARY 14, 2024

It’s essential to consult with a veterinarian experienced in cannabis treatment to determine the right product and dosage for your pet. By incorporating cannabis into your pet’s treatment plan under the guidance of a veterinarian, you may notice a significant improvement in their appetite.

Pets 98

Pets Medicine Treatment Conditions 98

Medicinal Genomics

APRIL 9, 2025

Without proactive monitoring and an integrated pest management (IPM) strategy, cultivators may face crop loss as well as increased costs from remediation efforts, regulatory compliance issues, and potential damage to brand reputation. Fusarium can cause root rot, crown rot, and wilting that can lead to total plant loss.

Environment 69

Environment Cultivation Research and Development Terpenes 69

Cannabis Law Report

JULY 9, 2021

– Canadian parent has remained in compliance with all FDA registrations and international guidelines. or under private label, is safe to use until the expiration date and remains in full compliance with all regulatory bodies. . – Restructured U.S. subsidiary removes $7.2 million of debt and future obligations.

Compliance 104

Compliance Compliance Business Conditions 104

Medicinal Marijuana Association

FEBRUARY 14, 2024

It’s essential to consult with a veterinarian experienced in cannabis treatment to determine the right product and dosage for your pet. By incorporating cannabis into your pet’s treatment plan under the guidance of a veterinarian, you may notice a significant improvement in their appetite.

Pets 95

Pets Medicine Treatment Conditions 95

Canna Law Blog

JANUARY 17, 2020

percent delta-9 tetrahydrocannabinol or opportunities for remediation or alternative uses; the feasibility of producer compliance with sampling timetables; the feasibility of producer compliance with reporting requirements; and. We simply don’t have enough information at this point to know what will happen.

Hemp 111

Hemp CBD Food Cannabinoids 111

Cannabis Law Report

JUNE 10, 2021

Currently, CURE uses its Schedule 1 DEA license for the development of Cannabis (THC) oral film products and other psychoactive substances, and manufactures multiple commercial Cannabidiol (CBD) products in compliance with the 2018 U.S. About CURE Pharmaceutical Holding Corp.

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

MMJ Recs

FEBRUARY 21, 2024

Healthcare providers can offer guidance on potential benefits, risks, and interactions with existing treatments. Understanding the legal and regulatory landscape is essential to ensuring compliance and responsible use. Legal and Regulatory Considerations: The legal status of medical marijuana varies globally and within regions.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

Cannabis Law Report

AUGUST 3, 2021

The Medicinal Cannabis Act and its applicable regulation specifically provide a list of covered health conditions for which medical cannabis treatment could be accepted. There must be a bona fide doctor-patient relationship between the doctor who issues the recommendation and the individual. Originally published at JD Supra.

Patients 105

Patients Law Research and Development Medicine 105

Cannabis Law Report

AUGUST 2, 2021

The Medicinal Cannabis Act and its applicable regulation specifically provide a list of covered health conditions for which medical cannabis treatment could be accepted. There must be a bona fide doctor-patient relationship between the doctor who issues the recommendation and the individual.

Patients 98

Patients Law Research and Development Medicine 98

Cannabis Law Report

NOVEMBER 18, 2019

percent THC as long as the production was in compliance with all legal requirements. Doctors can issue a prescription for herbal cannabis to support the original treatment and set out the type, the amount, and the method of consumption for each patient, which is either decoction or vaporising.

Supply Chain 77

Supply Chain Chronic Pain Consumption Cultivation 77

Cannabis Law Report

SEPTEMBER 1, 2021

Federal law requires that taxpayers must report income from illegal sources – including cannabis sales (whether state sanctioned or not) – raising numerous tax compliance and design issues. The lawful cannabis industry faces numerous regulatory hurdles that makes even good-faith compliance with the law a challenge. Introduction.

Policy 100

Policy Cannabis Law Treatment 100

Cannabis Law Report

JUNE 23, 2021

Additionally, Valcon Medical has been issued authorisation to handle euphoriant substances and issued a European Union Good Manufacturing Practice (EU GMP) certification for the manufacturing of medical cannabis extracts in compliance with the German Monograph for cannabis extracts, DAB Eingestellter Cannabisextract.

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86